{
    "clinical_study": {
        "@rank": "125878", 
        "acronym": "HFNOT", 
        "arm_group": [
            {
                "arm_group_label": "conventional oxygen therapy", 
                "arm_group_type": "No Intervention", 
                "description": "conventional nasal prong with FiO2 ~0.4"
            }, 
            {
                "arm_group_label": "HFNOT", 
                "arm_group_type": "Experimental", 
                "description": "high flow nasal oxygen therapy with starting FiO2 0.4 and Flow 40 L/min"
            }, 
            {
                "arm_group_label": "sham-HFNOT", 
                "arm_group_type": "Sham Comparator", 
                "description": "same device with FiO2 ~0.4, NO high flow"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the efficacy and safety of nasal high flow oxygen\n      therapy during diagnostic bronchoscopy."
        }, 
        "brief_title": "High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypoxia", 
        "condition_browse": {
            "mesh_term": "Anoxia"
        }, 
        "detailed_description": {
            "textblock": "Hypoxemia is frequently seen during diagnostic bronchoscopy. Nasal prong or other existing\n      oxygen supply methods are often difficult to maintain adequate oxygenation during\n      bronchoscopy. In particular, bronchoscopy to patients already showing hypoxemia can be\n      dangerous even though applying conventional oxygen therapy. Thus, we want to elucidate the\n      usefulness of nasal high flow oxygen therapy to hypoxemic patients undergoing diagnostic\n      bronchoscopy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: 1 or 2 or 3\n\n        1. PaO2 < 60 mmHg on ABGA or SpO2 < 90 % in room air AND SpO2 \u2265 95% or PaO2 \u2265 75mmHg in\n        low flow oxygen therapy 3. Planning to diagnostic bronchoscopic procedure(e.g. bronchial\n        washing, BAL, bronchoscopic biopsy, EBUS-TBNA etc.)\n\n        Exclusion Criteria:\n\n          1. patients who did not agree to provide information\n\n          2. patients requiring for emergent intubation\n\n          3. patients can not wear or be already applied high flow nasal oxygen therapy\n\n          4. patients with unstable vital sign(e.g. severe hypotension, uncontrolled arrhythmia,\n             etc.)\n\n          5. patients with multiple organ failures\n\n          6. patients with plan to therapeutic bronchoscopic procedure(e.g. intervention)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "114", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01650974", 
            "org_study_id": "E-1205-154-002", 
            "secondary_id": "H-1206-074-414"
        }, 
        "intervention": {
            "arm_group_label": [
                "HFNOT", 
                "sham-HFNOT"
            ], 
            "description": "high flow nasal oxygen therapy", 
            "intervention_name": "HFNOT", 
            "intervention_type": "Device", 
            "other_name": "high flow nasal oxygen therapy(OPTIFLOW)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "high flow nasal oxygen therapy", 
            "diagnostic bronchoscopy"
        ], 
        "lastchanged_date": "May 11, 2014", 
        "location": {
            "contact": {
                "email": "lungdrcho@snubh.org", 
                "last_name": "Young-Jae Cho", 
                "phone": "82-10-9925-7058"
            }, 
            "contact_backup": {
                "email": "subac1@naver.com", 
                "last_name": "Jisoo Park", 
                "phone": "82-10-6533-0452"
            }, 
            "facility": {
                "address": {
                    "city": "Seongnam", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-707"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }, 
            "investigator": {
                "last_name": "Young-Jae Cho, MD, MPH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy: A Prospective, Randomized, Controlled Study", 
        "overall_contact": {
            "email": "lungdrcho@snubh.org", 
            "last_name": "Young-Jae Cho, MD", 
            "phone": "82-10-9925-7058"
        }, 
        "overall_contact_backup": {
            "email": "subac1@naver.com", 
            "last_name": "Jisoo Park, MD", 
            "phone": "82-10-6533-0452"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital", 
            "last_name": "Young-Jae Cho, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Success is defined as completion of planned diagnostic procedure with the oxygen saturation or partial pressure of oxygen in arterial blood was similar to the level of before the procedure.\nFailure is defined as incompletion of planned diagnostic procedure due to sustained hypoxemia or else.\nFurthermore failure is defined as hypoxemia(SaO2 <88%) was developed more than 2 times even though planned procedure was completed.", 
            "measure": "Success rate of bronchoscopy", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01650974"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Young-Jae Cho", 
            "investigator_title": "Seoul National University Bundang Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "frequency and duration of hypoxia(oxygen saturation <88%) during procedure or after procedure.", 
                "measure": "frequency and duration of hypoxia", 
                "safety_issue": "Yes", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Increase oxygen apply or change of oxygen therapy method to high flow system.", 
                "measure": "switch to oxygen therapy method", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "scoring of dyspnea symptoms, patients's comfort.", 
                "measure": "change of respiratory symptoms", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}